Our Services
Welcome to HYDBIRD GmbH. Let us take you on a quick tour of our organisation: what we do and how you can benefit from our skills.
We bring out the best in each other and create strong and successful working relationships.
When it comes to advisory, HYDBIRD supports clients of all industry fields to reach their goals. We advise corporations as well as family-owned companies, industry- and service companies, global players and local heroes, the public sector, organisations and NGOs.
Technology Scouting
Technology scouting can be regarded as a method of technology forecasting or in the broader context also an element of corporate foresight.
Education & MOOC
MOOCs provide an affordable and flexible way to learn new skills, advance your career and deliver quality educational experiences at scale
Preclinical & Clinical Stage I Candidate Advisory
Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.
Business Project Partnering
project partnering is a relationship strategy whereby a project owner integrates contractors and other major contributors into the project
Medical Check-up and Vaccination Consulting
Medical Checkup is a medical procedure performed to detect, diagnose, or monitor diseases, disease processes, susceptibility, or to determine a course of treatment.
CDMO Partner Advisory
contract development and manufacturing organization is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
Our business includes:
CDMO
In recent years, pharmaceutical outsourcing has grown in popularity amongst drug developers across the industry. Companies are increasingly outsourcing to contract development and manufacturing organisations (CDMOs) due to the benefits outside expertise can bring to their business.
According to the Quintiles IMS Institute, the pharmaceutical industry is expected to be worth $1.5 trillion by 2021. The key trends driving this level of demand for pharmaceutical products include the world’s ageing population, rising healthcare standards in developing countries and expensive breakthrough therapies.
Medical Checkup
Despite the fact that China’s economy has recently been growing at a slower pace, the country has undergone a steady increase in both rural and urban disposable income. However, urban population experienced higher income growth rate, and they are the segment of the Chinese population that changed its lifestyle and consumption habits. It is noticeable that urban Chinese consumers are becoming to be more attached to more advanced needs, being the primary ones already satisfied, and especially one among them is becoming more and more crucial: healthcare.
Due to lack of drugs, surgeons with the necessary skills and advanced technology, many Chinese, looking for better quality and sometimes a lower price, travel overseas for medical treatments. Especially upper middle-class (with an annual disposable income from 106,000 to 229,000 RMB), affluent (with an annual disposable income major of 229,000 RMB) and high-net-worth individual (with an amount of investable assets major of 10 million RMB) are recurring to overseas medical treatments.
Pre-and Clinical Stage I Drug Candidate Advisory
One of the crucial steps in drug development is the selection of the most optimal clinical candidate, i.e. the NCE/NBE with the best chance of clinical success. For this purpose in vitro and in vivo studies are conducted to permit further selection of lead drug candidates with desirable absorption, distribution, metabolism, excretion, toxicology (ADMET) properties as well as pharmacology and efficacy to assist in the prediction of clinical ‘drug-like’ properties.
The majority of Chinese drugmakers rely on cheap production of generic medications to drive revenue, which means their profit margins are already slimmer than global rivals. New policy, called “带量采购“(procurement of drugs with target quantity), drives the profit further down the revenue. In order to maintain sustainable profit margin, old legacy pharmaceutical companies are looking for new drugs in early stage for out-licensing exclusively in Greater China Region.
IB Private School Advisory
Nowadays, early education is ever more significant to a person’s later career and personal development according a series of studies. With our expertise in German-speaking private schools, we are capable of finding a fitting school for your child.
In addition to the German Abitur, our students also complete the International Baccalaureate (IB) Diploma Programme. With this dual qualification they are ideally prepared for continuing their education at a German or an international university.